Bupropion XL 300mg Taper Schedule After 2 Years
For patients discontinuing bupropion XL 300mg after 2 years of therapy, reduce the dose to 150mg once daily for at least 1-2 weeks before complete discontinuation. 1
FDA-Approved Tapering Protocol
The FDA drug label for bupropion XL explicitly states: "When discontinuing treatment in patients treated with bupropion hydrochloride extended-release tablets (XL), 300 mg once daily, decrease the dose to 150 mg once daily prior to discontinuation." 1
This is the only evidence-based taper schedule specifically validated for bupropion XL and should be followed as the standard approach.
Practical Implementation
Standard Taper (Low-Risk Patients)
- Week 1-2: Reduce from 300mg to 150mg once daily in the morning
- After Week 2: Discontinue completely
Extended Taper (Higher-Risk Patients)
For patients with:
- History of difficult medication discontinuations
- Significant anxiety or mood symptoms
- Concerns about withdrawal effects
Consider:
- Week 1-2: 300mg to 150mg once daily
- Week 3-4: Continue 150mg daily (extended stabilization)
- After Week 4: Discontinue
Alternatively, for very cautious tapering:
- Week 1-2: 300mg to 150mg daily
- Week 3-4: 150mg every other day
- After Week 4: Discontinue
Key Clinical Considerations
Bupropion has minimal withdrawal syndrome risk. Unlike SSRIs or SNRIs, bupropion does not cause significant discontinuation symptoms in most patients. The FDA label mentions tapering primarily to minimize potential rebound effects rather than severe withdrawal 1.
Timing of administration matters. Continue taking the morning dose throughout the taper to minimize insomnia risk 2, 3.
Monitor for mood changes. While bupropion withdrawal is generally mild, watch for:
- Return of depressive symptoms (relapse vs. withdrawal)
- Increased irritability
- Sleep disturbances
- Fatigue
These typically emerge within 1-3 days if they occur 4.
Common Pitfalls to Avoid
Do not abruptly discontinue. Even though bupropion has lower withdrawal risk than other antidepressants, the FDA specifically recommends dose reduction before stopping 1.
Do not confuse withdrawal with relapse. If depressive symptoms emerge during or after tapering, distinguish between:
- Withdrawal: Typically resolves within days to 1-2 weeks
- Relapse: Persistent symptoms requiring treatment resumption
Do not use overly complex tapers. Unlike medications with severe withdrawal syndromes (benzodiazepines, opioids), bupropion does not require the months-long hyperbolic tapers described for other antidepressants 4, 5, 6. The simple two-step taper (300mg → 150mg → stop) is sufficient for most patients.
Special Populations
Hepatic impairment: Patients already on reduced dosing schedules due to liver disease should taper even more gradually, potentially extending the 150mg phase to 3-4 weeks 1.
Renal impairment: Similar caution applies; consider extending the 150mg stabilization period 1.
Concurrent psychiatric medications: If the patient is on other psychotropic medications, coordinate the taper with their prescriber to avoid compounding effects.
When to Pause or Reverse the Taper
If significant mood destabilization occurs:
- Pause at 150mg for 2-4 additional weeks
- Return to 300mg if clear relapse occurs (not just mild transient symptoms)
- Reassess the appropriateness of discontinuation with the patient
The evidence strongly supports that most patients can successfully discontinue bupropion XL using the straightforward FDA-recommended taper without significant complications 1.